Enlivex and Mount Sinai Health System Announce Research Collaboration for the Development of Allocetra in Combination with Immune Checkpoint Inhibitors

  • Carlos Cordon-Cardo,

Press/Media

Period1 Mar 2021

Media coverage

2

Media coverage